Menu Search
Equities

Cytophage Technologies Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CPTCF:PNK

Cytophage Technologies Ltd

Actions
  • Price (USD)0.2068
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change+8.84%
  • Beta--
Data delayed at least 15 minutes, as of Jul 21 2025.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Cytophage Technologies Ltd. is a Canadian biotechnology company focused on bacteriophage research, product development and commercialization. The Company’s business activity is to develop bacteriophages that will reduce and ultimately replace the use of antibiotics for illness prevention and treatment. Bacteriophages are viruses that only infect and kill bacteria. These natural killers of bacteria can overcome cellular or organism-level defenses. The Company is using de-risked and patented technology to advance products that harness the power of bacteriophages to combat bacterial infections affecting human health, animal health, and food security. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is a poultry health product offered by the Company.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-4.57m
  • Incorporated2019
  • Employees--
  • Location
    Cytophage Technologies Ltd200A-400 Fort Whyte WayOAK BLUFF R4G 0B1CanadaCAN
  • Phone+1 (416) 214-4810
  • Websitehttps://cytophage.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.